Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
Display:
Alarm as Ebola outbreak reaches 2,000 cases, picks up speed
The deadly Ebola outbreak in eastern Congo has surpassed 2,000 cases and is picking up speed. ... The outbreak declared in August, the second-deadliest in history, has killed more than 1,300 people in a volatile region where rebel attacks and community resistance have hurt containment efforts. ... Each attack keeps health workers from the crucial work of vaccinating people and tracking thousands of contacts of victims. ... Misunderstandings have been high in a region that had never [?!] experienced an Ebola outbreak until now
[...]
Amid the challenges, WHO and others have pointed out signs of progress. Notably, more than 129,000 people have received an experimental but effective Ebola vaccine in its first widespread use.
[11 June 2018, unidentified vaccine]
She said the hospital never showed her records confirming he'd tested positive for the virus.
[...]
Congo's health ministry and the WHO rushed in 7,500 doses, created by the Public Health Agency of Canada and owned by Merck.
[...]
The vaccine must be kept at a temperature of minus 76 to minus 112 degrees Fahrenheit (minus 60 to minus 80 degrees Celsius), and can only be kept in mobile freezers for up to seven days.
[...]
Next year, Merck plans to seek approval of the vaccine from the U.S. Food and Drug Administration, based on previous studies [?] of the shots. While the vaccine is[ not] being formally studied in the current Congo outbreak, regulatory authorities would want to know if unforeseen side effects crop up.

"If it's fully approved then in each outbreak it'll be the first measure and could be used all over the region," Dr. Jean-Jacques Muyembe, director general of the National Institute for Biomedical Research in Kinshasa told the AP.

In ["]West Africa["], a large study is underway that compares the Merck shot and a second vaccine candidate [?] made by Janssen Pharmaceuticals to determine best vaccination strategies and track how long [?!] protection lasts.

archived 4 May 2019
living lab 12 May 2018
Ebola Vaccines Shipped to Congo, WHO Chief Says; AFRICOM Gen.Thomas Waldhauser, Haley, Kabila 2017 bargaining

Diversity is the key to economic and political evolution.

by Cat on Tue Jun 4th, 2019 at 06:20:43 PM EST
[ Parent ]
Incidentally, the 2014 grilled-monkey-meat-on-a-stick-pathogen story is branching to favorable-climate-change-reservoir story. Developing ...

Diversity is the key to economic and political evolution.
by Cat on Thu Jun 6th, 2019 at 07:43:46 PM EST
[ Parent ]
UN health agency to remove controversial opioid guidelines
The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the potent painkiller OxyContin.
[...]
The congressional report released last month tracked how doctors and organizations tied to Purdue, including many of the leading figures who worked to expand opioid prescribing in the United States in the 1990s, influenced the WHO document. ... Clark described it as a "playbook" that the pharmaceutical industry is taking abroad, and that the WHO was "lending the opioid industry its voice and credibility."

Dr. Tedros Adhanom Ghebreyesus, director-general of the WHO, wrote to Clark and Rogers that the guidelines from 2011 and 2012 would be removed in "light of new scientific evidence that has emerged" and that the removal of the reports should address the allegations of conflicts of interest. Since the reports were first published, he wrote, the agency has strengthened its ethics polices.

preposterous. inconceivable. shocking. unprecedented. egregious.

Diversity is the key to economic and political evolution.
by Cat on Thu Jun 20th, 2019 at 09:43:40 PM EST
[ Parent ]

Display: